EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Beyond the 5-Year Window: Late-Onset Ocular Morbidity and a Proposed 10-Year Functional Survivorship Protocol for Pediatric Orbital Rhabdomyosarcoma

Hadeel Halalsheh iD, Yacoub A Yousef iD, Mona Mohammad iD, Ahmad Kh Ibrahimi iD, Iyad Sultan iD

Cancers · 19.05.2026 · 18 (10) · 1633

DOI: 10.3390/cancers18101633 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Cancers, online erschienen am 19.05.2026. Verfasst von Hadeel Halalsheh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, King Hussein Cancer Center, Queen Rania Street, Amman 11941, Jordan. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Hussein Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Orbital rhabdomyosarcoma (RMS) is the most common primary pediatric malignant orbital tumor, typically curable with chemotherapy and radiation. Data regarding MRI chemotherapy response and long-term ophthalmologic outcomes remain limited in non-cooperative-group settings.

Methods

We retrospectively reviewed children with primary orbital RMS treated at King Hussein Cancer Center (2002–2025) with vincristine, actinomycin-D, and cyclophosphamide (VAC). Pre-local-control MRI responses were classified as complete (CR), partial (PR), stable/minor (SD/MR), or progressive disease (PD). Survival and ophthalmologic outcomes were analyzed.

Results

Twenty-two patients (median age 5.6 years) were included. All had localized disease (77% low-risk). All received VAC; 20 (91%) received radiotherapy (median 45 Gy). Pre-radiotherapy MRI showed 8 (36%) CR and 11 (50%) PR. Four patients (18%) died. Five-year event-free survival (EFS) and overall survival (OS) were 73% and 84%, respectively. Cataracts developed in 45% of the cohort (50% of irradiated patients) at a median of 39.1 months (range 9.4–95.1). At last assessment, visual acuity was good in 60%, moderate in 25%, and severely impaired in 15%.

Conclusions

Excellent survival in orbital RMS is achievable in resource-stratified settings. Induction MRI progressive disease (PD) was associated with poor outcomes in this cohort and may represent an early prognostic signal warranting further validation in larger studies. Furthermore, the documented maximum cataract latency of 95 months suggests that the standard 5-year surveillance window is insufficient. These findings support extending ophthalmologic surveillance beyond the standard 5-year window. We propose, based on our retrospective institutional data, a 10-year functional survivorship framework.

Schlagwörter

Stichwörter der Autor:innen

EBRTJordanMRI responsechildrenophthalmologic late effectsorbitoutcomesrhabdomyosarcoma

Autor:innen und Institutionen

  • Department of Pediatrics, King Hussein Cancer Center, Queen Rania Street, Amman 11941, Jordan.
  • Department of Pediatrics, The University of Jordan, Amman 11941, Jordan.
  • Department of Surgery (Ophthalmology), King Hussein Cancer Center, Amman 11941, Jordan.
  • Department of Radiation Oncology, King Hussein Cancer Center, Amman 11941, Jordan.
  • Artificial Intelligence Office, King Hussein Cancer Center, Amman 11941, Jordan.

ORCID-Profile: Hadeel Halalsheh, Yacoub A Yousef, Mona Mohammad, Ahmad Kh Ibrahimi, Iyad Sultan

Förderung

  • King Hussein Cancer Center

Zitieren

APA

Halalsheh, H., Yousef, Y. A., Mohammad, M., Ibrahimi, A. K., & Sultan, I. (2026). Beyond the 5-Year Window: Late-Onset Ocular Morbidity and a Proposed 10-Year Functional Survivorship Protocol for Pediatric Orbital Rhabdomyosarcoma. Cancers, 18(10), 1633. https://doi.org/10.3390/cancers18101633

Vancouver

Halalsheh H, Yousef YA, Mohammad M, Ibrahimi AK, Sultan I. Beyond the 5-Year Window: Late-Onset Ocular Morbidity and a Proposed 10-Year Functional Survivorship Protocol for Pediatric Orbital Rhabdomyosarcoma. Cancers. 2026;18(10):1633. doi:10.3390/cancers18101633

BibTeX
@article{Halalsheh2026,
  author = {Halalsheh, Hadeel and Yousef, Yacoub A and Mohammad, Mona and Ibrahimi, Ahmad Kh and Sultan, Iyad},
  title = {Beyond the 5-Year Window: Late-Onset Ocular Morbidity and a Proposed 10-Year Functional Survivorship Protocol for Pediatric Orbital Rhabdomyosarcoma},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {10},
  pages = {1633},
  doi = {10.3390/cancers18101633}
}
Kostenlos starten →